Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Monaldi Hospital, 80131 Naples, Italy.
Department of Physiology of Nutrition, University of Naples "Federico II", 80138 Naples, Italy.
Genes (Basel). 2020 Aug 17;11(8):947. doi: 10.3390/genes11080947.
In this report, an atypical case of Noonan syndrome (NS) associated with sarcomeric hypertrophic cardiomyopathy (HCM) in a 33-year-old patient was described. Genetic testing revealed two different disease-causing mutations: a mutation in the PTPN11 gene, explaining NS, and a mutation in the MYBPC3 gene, known to be associated with HCM. This case exemplifies the challenge in achieving a definite etiological diagnosis in patients with HCM and the need to exclude other diseases mimicking this condition (genocopies or phenocopies). Compound heterozygous mutations are rare but possible in HCM patients. In conclusion, this study highlights the important role of genetic testing as a necessary diagnostic tool for performing a definitive etiological diagnosis of HCM.
本报告描述了一例非典型诺南综合征(NS)伴肌节肥厚型心肌病(HCM)的 33 岁患者。基因检测显示存在两种不同的致病突变:PTPN11 基因突变,解释了 NS;MYBPC3 基因突变,与 HCM 相关。该病例说明了在 HCM 患者中实现明确病因诊断的挑战,以及需要排除其他类似疾病(基因复制品或表型复制品)的必要性。复合杂合突变在 HCM 患者中较为罕见,但也有可能发生。总之,本研究强调了基因检测作为进行 HCM 明确病因诊断的必要诊断工具的重要作用。